Midwife Licensure Exam Newborn & Neonatal Care — Normal Newborn Assessment & CareStudy Notes

The APGAR score, named after Dr. Virginia Apgar, is a 5-component rapid assessment tool that evaluates a newborn's immediate adjustment to extrauterine life. It is performed at 1 minute and 5 minutes after birth—and repeated every 5 minutes up to 20 minutes if the score remains below 7. This is critical for the NLE: the APGAR guides ongoing observation and care escalation, not the timing of resuscitation. Resuscitation begins immediately based on the newborn's heart rate and breathing effort, not by waiting for the 1-minute APGAR score. The five components are abbreviated as **A-P-G-A-R**: **Appearance (Skin Color):** Assessed as 0 (blue/pale all over), 1 (body pink, extremities blue—acrocyanosis), or 2 (completely pink). Acrocyanosis, the bluish discoloration of hands and feet, is a normal physiologic response in the first 24 hours due to peripheral vasoconstriction and incomplete circulation to the extremities. This is benign and should not alarm the nurse or family; it is not counted as central cyanosis and costs only one point. **Pulse (Heart Rate):** Assessed by apical auscultation as 0 (absent), 1 (below 100 beats/min), or 2 (above 100 beats/min). The normal newborn heart rate ranges 110–160 beats/min at rest; it may elevate to ~180 when crying and drop to ~100 during sleep. In the immediate newborn period, a heart rate below 100 suggests poor transition and warrants oxygen and possible ventilation support. **Grimace (Reflex Irritability/Response to Stimulation):** Assesses the newborn's response to airway suctioning or tactile stimulation. Scored as 0 (no response), 1 (grimace/weak cry), or 2 (vigorous cry, cough, or sneeze). A robust cry indicates intact respiratory drive and brainstem reflexes. **Activity (Muscle Tone):** Assessed by observing spontaneous movement and response to handling as 0 (limp, flaccid), 1 (some flexion, weak tone), or 2 (active, well-flexed posture with resistance to extension). Newborns born in good condition assume a flexed posture due to the intrauterine position and intact central nervous system. **Respiratory Effort:** Assessed as 0 (absent/apneic), 1 (slow, irregular, or weak cry), or 2 (good, vigorous, strong cry with strong respiratory effort). This reflects the adequacy of spontaneous breathing and ventilation. **Interpretation and Clinical Action:** - **7–10 (Normal/Reassuring):** Good adjustment to extrauterine life. Provide routine newborn care, maintain skin-to-skin contact, and initiate early breastfeeding. - **4–6 (Moderately Depressed):** The newborn is depressed but not critically. Provide stimulation by drying, gentle suctioning if needed, and supplemental oxygen. Reassess at 1 minute if initial score was at 1 minute; a 5-minute score of 4–6 may indicate need for mild resuscitation measures and close observation. - **0–3 (Severely Depressed):** Immediate active resuscitation is required, including airway management, positive-pressure ventilation, and possible chest compressions. The nursing role is to support the resuscitation team, document findings, and prepare equipment. **Key NLE Point:** Remember that acrocyanosis is normal and benign. A newborn with a score of 7 (due to acrocyanosis) and strong cry, good heart rate, and active movement is making a normal transition. Do not over-interpret the score as pathologic based on color alone.

Accurate assessment of gestational age (the age of the fetus/newborn in completed weeks from the first day of the last menstrual period) is essential for risk stratification and management. Infants born before 37 weeks are classified as preterm, those born at 37–42 weeks as term, and those born after 42 weeks as post-term. An infant's gestational age, combined with weight-for-gestational-age status, predicts vulnerability to specific complications. The **New Ballard Score** is a validated tool that estimates gestational age using both **physical maturity** and **neuromuscular maturity** signs, and is most accurate when performed **within 12 hours of birth** (for very preterm infants) or up to **96 hours** of age. It is scored by examining specific physical findings (skin texture, lanugo distribution, plantar creases, breast tissue, ear cartilage, and external genitalia) and assessing neuromuscular maturity (posture, square window wrist flexibility, arm recoil, popliteal angle—knee flexibility, scarf sign, and heel-to-ear maneuver). **Physical Maturity Signs (visible at any age):** - **Skin:** Premature skin appears thin, transparent, and sticky; term skin is thicker, peeling may occur, and creases are visible on the sole. - **Lanugo:** Fine body hair present in preterm infants; sparse or absent in term infants. - **Plantar Creases:** Absent or few in preterm infants; deep creases covering the entire sole indicate term maturity. - **Breast Tissue:** Barely perceptible in preterm; prominent areolae with 5–10 mm breast bud in term infants. - **Ear:** Soft, pliable, with minimal cartilage in preterm; firm with well-defined cartilage in term. - **Genitalia (Males):** Testes undescended in preterm; descended and rugated scrotum in term. (Females: prominent clitoris in preterm; prominent labia majora covering minora in term.) **Neuromuscular Maturity Signs (reflect tone and posture):** - **Posture:** Preterm infants lie extended; term infants assume a flexed posture. - **Square Window (Wrist Flexion):** The angle formed when the hand is flexed onto the forearm. A 90° angle (or larger, cannot achieve flexion) indicates prematurity; a 0° angle (complete flexion) indicates maturity. - **Arm Recoil:** After extending the arms and releasing, term infants quickly return arms to flexed position; preterm infants remain extended. - **Popliteal Angle:** The angle at the knee when the thigh is flexed on the abdomen and the leg is extended. An angle >170° suggests prematurity; <90° suggests maturity. - **Scarf Sign:** Pull the hand across the chest toward the opposite shoulder. In preterm infants, the elbow crosses the midline; in term infants, it cannot. - **Heel-to-Ear:** Gently attempt to bring the heel toward the ear without forcing. Prematurity allows the heel to reach near the ear; term maturity prevents this due to increased flexor tone. Each sign is scored, and the scores are summed to estimate gestational age. The Ballard Score correlates the combined score to a gestational age in weeks. **Gestational Age Classification:** - **Preterm:** <37 weeks (high risk for respiratory distress syndrome, intraventricular hemorrhage, infection, temperature instability). - **Term:** 37–42 weeks (or 38–42 weeks by some standards; optimal maturity for extrauterine life). - **Post-term:** >42 weeks (increased risk for meconium aspiration, oligohydramnios, placental insufficiency). **Weight-for-Gestational-Age (WGA) Classification:** Plot the newborn's weight on a graph against gestational age: - **SGA (Small for Gestational Age):** Weight <10th percentile for age. Associated with intrauterine growth restriction (IUGR), often from maternal hypertension, placental insufficiency, or intrauterine infections. SGA infants are at risk for hypoglycemia, hypothermia, and polycythemia. - **AGA (Appropriate for Gestational Age):** Weight 10th–90th percentile. Normal growth trajectory. - **LGA (Large for Gestational Age):** Weight >90th percentile. Often seen in infants of diabetic mothers. LGA infants are at risk for birth trauma (shoulder dystocia, clavicular fracture), hypoglycemia (from maternal hyperglycemia driving fetal hyperinsulinism), and respiratory distress. The combination of gestational age and WGA status is powerful prognostication. For example, a preterm SGA infant faces compounded risks (early delivery PLUS poor intrauterine growth), whereas a term AGA infant has the most favorable outlook.

Establishing baseline vital signs and measurements is a foundational skill. Normal ranges differ markedly from older children and adults, and the nurse must distinguish normal variation from pathology. **Heart Rate (HR):** The normal resting apical heart rate in a healthy newborn is **110–160 beats/min**. Heart rate varies with activity: it may elevate to ~180 beats/min when the infant cries or is stimulated, and may drop to ~100 beats/min during deep sleep. **Count the apical pulse for a full 60 seconds** to obtain an accurate rate, as newborn rhythms are often irregular. Bradycardia (HR <100 at rest) in the newborn period may indicate cardiac anomaly, hypothermia, or perinatal depression and warrants investigation. Tachycardia (HR >160 at rest) may reflect fever, pain, anemia, or cardiac disease. A murmur detected on auscultation does not automatically indicate pathology—many newborns have innocent functional murmurs that resolve within the first days or weeks as fetal shunts (foramen ovale, ductus venosus) close. **Respiratory Rate (RR):** The normal newborn respiratory rate is **30–60 breaths/min**, typically irregular and abdominal (the diaphragm is the primary muscle; chest wall excursion is minimal). Periodic breathing—brief pauses lasting **under 15–20 seconds**—is a normal variant and does not indicate apnea (which is defined as cessation of breathing for ≥20 seconds associated with bradycardia or hypoxia). Do not alarm the family if the infant has momentary pauses in breathing. RR >60/min (tachypnea) may indicate respiratory distress, fever, or metabolic acidosis. RR <30/min may suggest depression or inadequate ventilation. Observe for **signs of respiratory distress:** grunting (a sound heard at end-expiration), nasal flaring, intercostal or subcostal retractions, and seesaw respirations (abdomen in while chest retracts). The presence of these signs warrants escalation of care and possible oxygen supplementation. **Temperature:** The preferred site for newborn temperature measurement is the **axilla (armpit)**, where the normal range is **36.5–37.5°C** (97.7–99.5°F). Rectal temperature is more accurate but carries risk of perforation in a newborn's delicate rectum and is generally avoided in well newborns. Tympanic and temporal thermometers are less reliable in newborns. Temperature >37.5°C is fever and may indicate infection; temperature <36.5°C is hypothermia and impairs metabolism, oxygenation, and feeding. Cold stress is a serious concern in the newborn (see Thermoregulation section). The newborn's ability to generate heat through non-shivering thermogenesis (metabolizing brown fat) is essential, and environmental control is critical. **Blood Pressure:** Blood pressure is **not routinely measured in healthy, well-appearing newborns**. When measured (e.g., in sick or preterm infants), the normal range is approximately **60–80 mmHg systolic / 40–50 mmHg diastolic**. Mild hypotension may be normal in the first hours of life; significant hypotension suggests hypovolemia, sepsis, or cardiac compromise. **Weight:** Normal newborn birth weight ranges **2,500–4,000 g**, with an average of approximately **3,400 g** (7.5 lbs). Weight loss of **5–10% in the first 3–5 days** is physiologic (due to loss of extracellular fluid, meconium, and urine) and should be regained by **10–14 days of age**. Weight loss exceeding 10% or failure to regain birth weight by 14 days may indicate inadequate feeding, dehydration, or illness and warrants intervention (lactation support, supplementation, or medical evaluation). Always document the birth weight, current weight, percentage loss, and feeding plan in the health record. **Length:** Normal newborn length is **45–55 cm**, with an average of approximately **50 cm** (19.5–21.7 inches). Length is measured supine from the top of the head to the sole of the foot with the leg extended. Some shortening may occur within 24–48 hours due to relaxation of flexor tone; this is not true growth loss. Length is measured again at hospital discharge and at well-baby visits to track growth. **Head Circumference (HC) and Chest Circumference:** The normal head circumference is **33–35 cm** (approximately **13–14 inches**), and the chest circumference is **30–33 cm** (approximately **12–13 inches**). **The head circumference should be 2–3 cm larger than the chest circumference.** A head circumference much larger (>90th percentile for age) may indicate hydrocephalus; one much smaller may indicate microcephaly. Measure the HC at the widest point passing over the occiput and the anterior fontanelle. Document these measurements and compare to growth charts and standardized percentiles appropriate for the infant's gestational age and gender. **Blood Glucose:** Capillary or venous blood glucose should remain **above 45 mg/dL** (some sources cite >40–45 mg/dL as the threshold for concern). Newborns are vulnerable to hypoglycemia, especially in the first 12–24 hours, because glucose stores are limited and metabolic demands are high. Risk factors include maternal diabetes, prematurity, SGA, cold stress, and poor feeding. Signs of hypoglycemia include jitteriness, tremors, poor feeding, lethargy, seizures, and apnea. **Routine screening at 30 minutes and 2–4 hours of age** is recommended for at-risk infants; breastfed term AGA infants with good feeding may not require routine screening if monitored clinically. If glucose <45 mg/dL, feed the infant (breast or formula) and recheck in 15–30 minutes. If the infant cannot feed or glucose remains low, IV dextrose is initiated. Always inform the mother and document findings.

Primitive reflexes are involuntary responses present at birth (or emerge shortly after) and reflect an intact brainstem and spinal cord. Their presence confirms normal neurologic function; their absence or asymmetry raises concern for injury or disease. These reflexes gradually disappear as the central nervous system matures and voluntary control develops—this is both normal and expected. **Rooting Reflex:** Stroke or touch the infant's cheek near the mouth → the head turns toward the stimulus and the mouth opens in search of a feeding source. This reflex is essential for successful breastfeeding and is present from birth. It disappears around 3–4 months of age when voluntary feeding control develops. If absent, consider prematurity, depression, or neurologic injury. **Sucking Reflex:** Place an object (finger, pacifier, or breast) in the infant's mouth → the infant sucks vigorously. This reflex is strongest 15–20 minutes after birth and gradually integrates with voluntary sucking. It fades around 10–12 months of age. A weak or absent suck in a term infant may indicate central nervous system depression, infection, or anatomic anomaly (cleft palate). **Palmar Grasp Reflex:** Place your finger in the infant's palm → the fingers curl around it in a tight grasp. This reflex is strong and can support the infant's weight. It fades around 3–4 months of age. Asymmetry (one hand grasping stronger than the other) may suggest brachial plexus injury or weakness on one side. **Plantar Grasp Reflex:** Press the sole of the foot just below the toes → the toes curl or flex. Similar to palmar grasp, this reflex disappears around 8 months of age. Asymmetry warrants further evaluation. **Moro (Startle) Reflex:** A sudden, unexpected stimulus—such as a loud noise, a jolt, or a quick change in head position (e.g., allowing the head to drop slightly back without support)—triggers the Moro reflex. The infant's arms abduct (spread out) and extend, the fingers fan open (the thumb and index finger form a "C"), and then the arms come back together in an embrace. The reflex may be accompanied by a cry. The Moro disappears around 5–6 months of age. **Critical NLE Point:** **Asymmetry of the Moro reflex is highly significant.** Asymmetry (for example, the left arm does not abduct or extends weakly) suggests: - **Fractured clavicle:** The infant cannot move that arm freely due to pain or instability. Examine for swelling or crepitus along the clavicle. - **Brachial plexus injury (Erb palsy):** Occurs from traction on the arm during delivery. The affected arm may hang limply or show reduced movement. In Erb palsy, the 5th and 6th cervical nerves are stretched or torn, affecting shoulder and arm function. The nurse must carefully perform and document the Moro reflex on every newborn. If asymmetry is noted, inform the physician immediately, document the finding with a clear description, and prepare for further assessment (imaging, neurology consultation). **Tonic Neck Reflex (Fencing Reflex):** Turn the infant's head to one side → the arm and leg on that side extend, while the opposite arm and leg flex (creating a "fencing" posture). This reflex appears at birth and fades around 4 months of age. Asymmetry or persistence past 4 months may indicate neurologic abnormality. **Babinski Reflex:** Stroke the sole of the foot from heel toward the toes along the lateral border → the great toe dorsiflexes (bends upward) and the other toes fan or splay outward. This is a **normal finding in infants** and reflects the immaturity of the corticospinal tract. The Babinski remains normal in infants until about 12 months of age, after which a positive Babinski in a child or adult indicates upper motor neuron disease (abnormal in adults). Do not confuse infant Babinski with pathology. **Stepping (Dancing) Reflex:** Hold the infant upright with feet touching a surface → the infant makes stepping motions as if walking. This reflex is present at birth and disappears around 2 months of age as voluntary locomotion develops. **Galant Reflex (Trunk Incurvation):** Stroke the infant's skin along the side of the spine from shoulder to hip → the trunk curves toward the stimulus. This reflex is present at birth and disappears by 2 months of age. Asymmetry may indicate spinal or neurologic abnormality. **Clinical Significance in NLE Context:** The nurse assesses reflexes as part of the newborn neurologic exam. Present and symmetric reflexes indicate good neurologic status and intact brainstem/spinal cord function. Absent, diminished, or asymmetric reflexes warrant documentation and physician notification. For example, a depressed newborn (low APGAR) may have diminished reflexes that improve as the infant stabilizes. A newborn with an asymmetric Moro must be evaluated for birth trauma. Always document the findings in clear, specific language (e.g., "Moro reflex present and symmetric bilaterally" vs. "Left Moro reflex diminished; clavicle palpated for crepitus—none noted; assess for Erb palsy").

The newborn is highly vulnerable to heat loss and cannot effectively generate heat through shivering. Instead, newborns rely on **non-shivering thermogenesis**—the metabolic breakdown of **brown fat** (brown adipose tissue), a specialized fat depot rich in mitochondria found in the interscapular region, around the neck, and in the axillae. This metabolic process generates heat but demands significant oxygen and glucose, making cold stress a serious risk. **Why Newborns Lose Heat Rapidly:** 1. **Large surface area-to-body mass ratio:** Newborns have proportionally more skin surface compared to their mass. 2. **Thin skin and minimal subcutaneous fat:** The skin provides little insulation, especially in preterm infants. 3. **Inability to shiver:** Shivering is not an effective heat-generation mechanism in newborns. 4. **Limited voluntary behavior:** Newborns cannot adjust clothing or move to warmer areas. 5. **Immature hypothalamic thermoregulation:** The newborn's ability to sense cold and respond is still developing. **The Four Routes of Heat Loss (Remember: E-C-C-R):** **Evaporation:** Heat is lost as moisture on the skin evaporates. This is the most rapid route of heat loss in the wet newborn immediately after birth. **Immediate and thorough drying is the single most important intervention** to prevent heat loss in the delivery room. **Conduction:** Direct transfer of heat to cooler objects touching the skin. Examples include contact with cold delivery instruments, unwarmed blankets, cold scales, or cold hands of caregivers. Prevention: warm all surfaces (blankets, scales, hands), use prewarmed incubators or radiant warmers, and avoid contact with cold metal or surfaces. **Convection:** Heat loss to the surrounding air, especially when air is moving. Drafts, open windows, air-conditioning, and fan-driven air movement all cause convective heat loss. Prevention: avoid drafts, keep the infant away from air-conditioning vents and open windows, and maintain a draft-free environment. **Radiation:** Heat loss to cooler objects not in direct contact but in the immediate environment. For example, heat radiates away from an infant placed near a cold window or outer wall. Prevention: keep the infant away from external windows and cold walls; use a radiant warmer; maintain a warm environmental temperature. **Consequences of Cold Stress:** Cold stress triggers compensatory non-shivering thermogenesis, which dramatically increases metabolic rate and oxygen consumption. This leads to: - **Hypoglycemia:** Increased glucose consumption for heat generation; depletion of glycogen stores; risk of seizures and developmental delay if prolonged. - **Respiratory distress:** Increased oxygen demand; metabolic acidosis if oxygen supply is insufficient; risk of apnea. - **Peripheral vasoconstriction:** Reduced blood flow to skin; increased risk of skin injury and poor perfusion. - **Acidosis:** Anaerobic metabolism from poor tissue perfusion; increased risk of cardiac arrhythmias and reduced cardiac output. - **Increased blood viscosity:** From cold-induced hemoconcentration; risk of thrombosis. **Preventing Heat Loss: The EINC/Unang Yakap Approach and Beyond:** 1. **Immediate and Thorough Drying (within 30 seconds):** This is the cornerstone of thermoregulation. Dry the infant completely, including the hair (a major heat-loss site), and replace wet blankets immediately with warm, dry blankets. This single action prevents evaporative heat loss and stimulates breathing. 2. **Skin-to-Skin Contact:** Place the naked infant **prone on the mother's bare chest/abdomen** (this is called **kangaroo care** in the EINC protocol). Cover both mother and infant with a warm blanket. This provides: - Conductive warmth from the mother's body (mothers naturally regulate skin temperature ~0.5°C higher when holding an infant). - Psychological comfort and bonding. - Colonization of the infant's skin with maternal beneficial flora. - Early initiation of breastfeeding. - **This is the preferred method of thermoregulation** and is now standard in the Philippines under the EINC/Unang Yakap protocol. 3. **Hat and Cap:** Apply a knitted or cloth cap to cover the entire head. The head is a major site of heat loss (proportionally ~10–15% of body surface area) due to its large surface area. A simple cap can reduce heat loss significantly. 4. **Avoid Unnecessary Exposure:** Minimize the time the infant is undressed. If assessment or procedures are needed, work quickly and cover the infant as soon as possible. For example, do not leave the infant exposed on a scale; weigh efficiently and return to warmth. 5. **Warm the Environment:** - Use a **radiant warmer** for preterm, SGA, or compromised infants. Set the thermostat to maintain skin temperature at 36.5–37.5°C (use a skin temperature probe attached to the infant's abdomen or scapula). - Use an **incubator** for infants requiring prolonged warmth, especially if undergoing procedures. - Keep the ambient temperature warm; avoid air-conditioning directly on the infant. 6. **Warm all Supplies and Equipment:** - Preheat blankets and clothing. - Warm your hands before touching the infant. - Use warm water for any washing or procedures. - Preheat the scales or incubator before placing the infant. 7. **Delay the First Bath:** The EINC protocol recommends **delaying the first bath for at least 6 hours** (ideally 24 hours or until the infant's temperature is stable and >37°C). This allows time for the infant to adjust to extrauterine temperatures and reduces evaporative heat loss from bathing. Bathing can be deferred, as vernix caseosa (the white, cheesy coating on the skin) provides natural skin protection. **NLE Focus: Thermoregulation as a Nursing Diagnosis** The nursing diagnosis **"Ineffective Thermoregulation"** or **"Risk for Hypothermia"** (using NANDA-I language) is relevant for newborns, especially preterm or SGA infants. Nursing interventions are grounded in the heat-loss prevention strategies above: - Monitor axillary temperature q30min–q1h until stable, then per protocol. - Provide immediate drying and warm blankets. - Place on mother's chest or use radiant warmer/incubator. - Apply cap, minimize exposure, ensure warm environment. - Use warm blankets, preheat equipment, warm hands. - Delay bathing; provide verbal reassurance to family. - If hypothermia develops, gradually rewarm (avoid rapid rewarming, which can cause "afterdrop"—a paradoxical further drop in core temperature due to peripheral vasodilation). Accurate, frequent temperature monitoring is essential. Always document the route, time, and temperature. If the infant's temperature falls below 36.5°C, escalate care immediately—this is a sign of inadequate thermoregulation and may indicate illness or environmental failure.

In the Philippines, the Department of Health (DOH) has standardized immediate care for all newborns through the **Essential Intrapartum and Newborn Care (EINC)** program, commonly known as **"Unang Yakap"** (First Embrace or First Hug). This protocol, aligned with WHO recommendations, is now the standard of care in all Philippine healthcare facilities and is tested extensively on the NLE. The EINC protocol emphasizes evidence-based, time-bound interventions that prioritize the newborn's physiologic transition, early bonding, and breastfeeding initiation while minimizing unnecessary separation or interventions. **The Four Core Time-Bound Steps of EINC/Unang Yakap:** **Step 1: Immediate and Thorough Drying (Within the First 30 Seconds)** Upon delivery, the wet newborn is immediately and completely dried with warm, dry towels or blankets. The drying process: - Removes the amniotic fluid covering the skin, which promotes rapid heat loss through evaporation. - Stimulates the newborn to take deep breaths and cry (a tactile stimulus). - Prepares the skin for skin-to-skin contact. - Prevents hypothermia, the leading cause of avoidable neonatal morbidity and mortality. The head and hair are dried thoroughly, as the head accounts for a disproportionately large heat-loss area. Wet blankets are immediately replaced with warm, dry blankets. If the newborn has passed meconium in utero and is not vigorous (i.e., has poor cry, low tone, or inadequate respiratory effort), the mouth and nose are suctioned with a bulb syringe to clear airways before drying; otherwise, routine suctioning is **not** performed (this is a change from older practice—suctioning of vigorous newborns increases risk of vagal stimulation and bradycardia and is now discouraged). **Step 2: Early Skin-to-Skin Contact (Immediate, Maintained for at Least 1 Hour or Until First Feed)** Immediately after drying, the fully naked newborn is placed **prone (face-down) on the mother's bare chest or abdomen**—this is the optimal position for skin-to-skin contact, also called **kangaroo care**. Both mother and infant are then covered with a warm blanket. This step: - Provides conductive warmth: the mother's body naturally maintains a higher skin temperature and can adjust it in response to the infant's temperature. - Promotes bonding and early establishment of the mother-infant relationship. - Facilitates early assessment of feeding cues (rooting, hand-to-mouth movements). - Provides maternal colonization: the infant's skin is colonized with the mother's normal flora, providing protection against pathogenic organisms. - Supports early lactation: skin-to-skin contact triggers the release of oxytocin in the mother, promoting uterine contraction and milk let-down. - Reduces the infant's stress response and promotes more stable vital signs and temperature. - Allows the health worker to perform initial assessment (breathing, cry, color, tone) without separating mother and infant. Unless there is a contraindication (e.g., the mother is medically unstable or the infant requires immediate resuscitation), skin-to-skin contact should begin within the first few minutes and continue for at least **1 hour**. During this time, initial assessments (vital signs, APGAR score at 1 minute, initial physical examination) are performed with the infant in contact with the mother when possible. At the end of the skin-to-skin contact period, if breastfeeding has not yet occurred, the infant remains close to the mother (rooming-in). **Step 3: Properly Timed Cord Clamping (After Cord Pulsations Cease, Approximately 1–3 Minutes After Birth)** Traditionally, the umbilical cord was clamped immediately after delivery. Current evidence supports delayed clamping to improve the newborn's iron stores and reduce anemia. The cord is allowed to continue pulsating (which indicates continued blood flow from the placenta to the infant) for approximately **1–3 minutes after the infant takes the first breath**. This allows additional blood volume to transfer from the placenta to the infant, improving oxygen-carrying capacity and iron stores. Benefits include: - Increased hemoglobin levels at birth (reduces neonatal anemia). - Improved iron stores in the first 4–6 months of life (reducing the need for early iron supplementation). - Reduced need for neonatal blood transfusion in preterm infants. - Better cardiopulmonary adaptation (the increased blood volume supports circulation and oxygenation). Delayed cord clamping is contraindicated in rare cases (e.g., placental abruption with rapid maternal blood loss, cord prolapse requiring immediate clamping) or when the infant requires immediate resuscitation away from the mother. In term infants, 1–3 minutes of delay is standard; in preterm infants, delayed clamping may be extended if feasible. The cord is clamped and cut once pulsations have stopped or in the above situations. **Step 4: Non-Separation of Mother and Newborn for Early Initiation of Breastfeeding (Rooming-In; First Breastfeed Ideally Within the First 90 Minutes)** After the delivery of the placenta and initial care, mother and newborn remain together in the same room (rooming-in). Routine procedures—such as measurement, bathing, and administration of prophylactic medications—are performed at the bedside while the mother and infant are together, or are delayed to allow uninterrupted time for bonding and early feeding. The newborn is placed on the mother's breast or chest to encourage **early initiation of breastfeeding**, ideally **within the first 90 minutes of life**. Early breastfeeding: - Stimulates oxytocin release, promoting uterine contraction and reducing postpartum hemorrhage risk. - Begins transfer of maternal antibodies and beneficial factors (colostrum is rich in IgA, lactoferrin, and leukocytes). - Helps establish milk production and supply. - Promotes bonding and reduces maternal stress. - Provides natural glucose and hydration to the newborn. - Stimulates the newborn's digestive system. The EINC protocol emphasizes that the decision to separate mother and infant for procedures (such as administration of vitamin K, eye prophylaxis, or newborn screening blood draw) is individualized based on the clinical situation and the family's preference. When possible, these procedures are performed with the infant on or near the mother, or are briefly delayed to allow early feeding. **Discouraged or Deferred Interventions Under EINC:** The EINC protocol explicitly discourages several routine practices that were previously standard: - **Routine Suctioning of Vigorous Newborns:** A vigorous newborn (with good cry, adequate respiratory effort, and normal tone) does not require suctioning. Routine suctioning increases risk of vagal stimulation, bradycardia, and aspiration. Suctioning is reserved for newborns with meconium-stained amniotic fluid and poor vigor, or those with apparent airway obstruction. - **Early Bathing:** The first bath should be delayed **at least 6 hours** (ideally 24 hours) or until the infant's temperature has stabilized above 37°C. Bathing in the first hours causes evaporative heat loss and removes vernix caseosa, a natural protective coating. Families can be reassured that vernix provides skin protection and hydration. - **Unnecessary Separation for Procedures:** Measurements, physical examination, administration of eye drops and vitamin K, and other routine procedures are performed at the bedside with the infant on the mother, or are deferred to allow early feeding and bonding. - **Footprinting and Identification:** In some settings, elaborate footprinting or identification procedures may be streamlined or deferred. The focus is on accurate maternal-infant identification (via wristbands or identification systems in use at the facility) without unnecessary separation. **Nursing Implications of EINC in Philippine Context:** As a Filipino BSN graduate, you are expected to know and practice the EINC/Unang Yakap protocol as the standard. This is part of the **Reproductive Health Service Delivery Framework** and is aligned with Philippine nursing practice law (RA 9173), which mandates that nurses deliver care based on best evidence and in accordance with DOH standards. When caring for a newborn and family immediately after delivery: 1. **Ensure immediate, thorough drying** of the newborn within 30 seconds of delivery. This is your highest priority. 2. **Place the infant skin-to-skin with the mother** as soon as possible, covering both with warm blankets. Perform initial assessment (APGAR, vital signs) with the infant on the mother when feasible. 3. **Delay cord clamping** for 1–3 minutes unless contraindicated. Observe for cord pulsations to stop, then clamp and cut. 4. **Implement rooming-in** and facilitate early breastfeeding within the first 90 minutes. Provide lactation support and teach the mother about feeding cues (rooting, hand-to-mouth movements). 5. **Defer or streamline routine procedures** to avoid unnecessary separation. Perform vitamin K, eye drops, and other medications at the bedside, or delay them slightly to allow early feeding (e.g., administer eye drops after the first breastfeed). 6. **Delay the first bath** for at least 6 hours. Counsel the family that this is the standard practice to preserve warmth and vernix benefits. 7. **Provide clear verbal and written information** to the family about the rationale for EINC practices, early signs of adequate feeding (wet diapers, stooling, infant contentment), breastfeeding support, and danger signs requiring medical attention. 8. **Document all care** in the health record, including time of skin-to-skin contact, cord clamping time, first feed attempt and time, and any procedures performed. Use standard EINC documentation forms if available in your facility.

Several medications and vaccines are administered to all newborns within the first hours or days of life to prevent serious, treatable conditions. These are standardized protocols in the Philippines and are components of the EINC and Philippine Expanded Program on Immunization (EPI). **Vitamin K (Phytonadione):** Dose and Route: **0.5–1 mg IM (intramuscularly)**, usually **1 mg**, given as a single dose in the **vastus lateralis muscle** (the outer thigh) within the first few hours of life, ideally before the first feed or after completion of the first feed. Rationale: Vitamin K is essential for the synthesis of clotting factors II, VII, IX, and X (the **vitamin K–dependent factors**). The newborn's intestines are sterile at birth and cannot synthesize vitamin K, which is normally produced by gut bacteria. Additionally, maternal vitamin K stores are not efficiently transferred across the placenta. Without supplementation, newborns are at risk for **vitamin K–deficiency bleeding (VKDB)**, formerly called **hemorrhagic disease of the newborn**. VKDB can present as: - **Early VKDB** (0–24 hours of life): Rare; usually associated with maternal use of vitamin K antagonists (warfarin) during pregnancy. - **Classic VKDB** (1–7 days of life): More common; presents as bleeding from the umbilicus, gastrointestinal tract, or widespread ecchymoses and can progress to intracranial hemorrhage if untreated. - **Late VKDB** (1–12 weeks): Associated with exclusive breastfeeding (breast milk is low in vitamin K) and can present with intracranial hemorrhage or hemarthrosis (bleeding into joints), causing permanent neurologic damage or death. Administration of vitamin K at birth (and continued supplementation for exclusively breastfed infants or those at risk) prevents VKDB. Vitamin K also accumulates in the infant's liver and builds reserves; gut colonization by bacteria in the subsequent weeks further supports endogenous vitamin K synthesis. Always administer vitamin K IM in the vastus lateralis to reduce pain (the vastus lateralis has fewer nerve endings than the deltoid and is the preferred site for IM injections in newborns). **Erythromycin 0.5% Ophthalmic Ointment:** Dose and Route: **0.5% erythromycin ointment, approximately 1 cm ribbon**, instilled into the **lower conjunctival sac of both eyes**. Application is typically performed within the first few hours of life, ideally after initial mother-infant bonding and the first breastfeed (per EINC protocol, eye drops/ointment can be deferred slightly to allow early feeding). Rationale: The newborn's eyes are exposed to maternal genital secretions during vaginal delivery. Untreated maternal infections—particularly **Neisseria gonorrhoeae (gonorrhea)** and **Chlamydia trachomatis (chlamydia)**—can cause **ophthalmia neonatorum** (acute conjunctivitis in the newborn), which presents as purulent discharge, eyelid swelling, and hyperemia 2–5 days after birth. If untreated, these infections can cause corneal scarring, vision loss, and blindness. Erythromycin ointment (or alternative prophylactic agents such as silver nitrate, povidone-iodine, or ceftriaxone) prevents ophthalmia neonatorum by eliminating pathogens from the conjunctiva. **Instill gently into both eyes**, ensuring the ointment reaches the entire conjunctival sac. The infant may experience transient chemical irritation or mild conjunctival redness, which is normal. Note: In the Philippines, erythromycin is widely available and commonly used; alternative agents (such as silver nitrate) may be used in some facilities, but all have similar efficacy. Some high-risk infants (e.g., those born to mothers with untreated gonorrhea or chlamydia) may also require systemic prophylaxis or treatment in addition to topical eye prophylaxis. **Hepatitis B Vaccine:** Dose and Route: **5 μg (0.5 mL) IM** (for most infant formulations in the Philippines) into the **anterolateral thigh (vastus lateralis)**, within **24 hours of birth** (ideally within the first 12 hours). In the Philippines, the hepatitis B vaccine is part of the Universal Immunization Program and is administered at birth, followed by additional doses at 1.5 months and 6 months of age (the 0-1.5-6 month schedule). Rationale: Vertical transmission of hepatitis B virus (HBV) from mother to newborn can occur, especially in mothers with hepatitis B surface antigen (HBsAg) positivity. Neonatal HBV infection carries a very high risk (>90%) of chronic hepatitis B and lifelong complications (cirrhosis, hepatocellular carcinoma). Vaccination at birth prevents vertical transmission and subsequent chronic infection. The vaccine is highly efficacious (>95%) when administered promptly. If the mother is known to be HBsAg-positive or status is unknown, the newborn should also receive **hepatitis B immunoglobulin (HBIG)** within 12 hours of birth for additional passive immunity (this is particularly important for HBsAg-positive mothers). The combination of vaccine (active immunity) and HBIG (passive immunity) provides near 100% protection. All newborns in the Philippines, regardless of maternal status, receive the birth dose of hepatitis B vaccine as part of routine care. **Bacille Calmette-Guérin (BCG) Vaccine:** Dose and Route: **0.05 mL (for infants <1 year) or 0.1 mL (for older children and adults)** administered **intradermally** at the deltoid region (upper arm), at **birth or within the first week of life**. In the Philippines, BCG is part of the Expanded Program on Immunization (EPI) and is typically given at the initial visit to the health facility (often within the first day or two if not given at the birthing facility). Rationale: BCG provides protection against tuberculosis (TB), particularly severe forms like TB meningitis in infants. Tuberculosis remains a significant public health concern in the Philippines, and BCG vaccination at birth is part of the national TB prevention strategy. The vaccine is administered intradermally (between the layers of the skin) and should create a small, blanched papule at the injection site; this papule typically disappears within a few minutes. A local lymphadenitis (swelling of the lymph node) may develop 2–8 weeks after vaccination and is a normal response; it usually resolves spontaneously. BCG should not be given to immunocompromised infants (e.g., HIV-positive) due to risk of disseminated BCG disease. **Hepatitis A Vaccine (Not Routine at Birth):** In some regions or high-risk populations, hepatitis A vaccine may be recommended, but it is not part of the routine neonatal schedule. It is typically first administered at 12 months of age. **Timing of Administration and Nursing Documentation:** According to EINC and Philippine EPI guidelines: - **Vitamin K:** Within the first hours, after drying and initial skin-to-skin contact (can be given before or after first feed). - **Eye prophylaxis (erythromycin):** Can be delayed slightly (up to 1 hour) after birth to allow skin-to-skin contact and early breastfeeding; then both eyes are treated. - **Hepatitis B vaccine:** Within 24 hours of birth, ideally within the first 12 hours; can be administered at the same site or different site from vitamin K (usually administered IM in the opposite vastus lateralis). - **BCG:** Within the first week, often given at the initial health facility visit (at a different site, intradermally at the deltoid). **Nursing Considerations:** 1. **Always verify the infant's identity** before administering any medication using the mother-infant identification band or facility protocol. 2. **Document** the medication name, dose, route, site, time, and any adverse reactions in the health record and on the infant's immunization card (the yellow vaccine card in the Philippines). 3. **Maintain aseptic technique** when administering injections; use a new sterile needle and syringe for each injection. 4. **Educate the family** about the rationale for each medication/vaccine and any expected reactions (e.g., BCG papule, local vitamin K hematoma at IM site). 5. **Observe the infant** for allergic reactions (rare but possible, especially with antibiotic eye prophylaxis in infants with ocular sensitivity). 6. **Ensure the immunization card is filled out completely** and given to the family; this is the official record of the infant's vaccinations and is used at all subsequent health encounters. 7. **Verify that the vaccine cold chain was maintained** (all vaccines must be stored at appropriate temperatures to maintain potency). **NLE Focus: These are HIGH-YIELD facts that are frequently tested. Remember:** - Vitamin K 0.5–1 mg IM prevents vitamin K–deficiency bleeding (VKDB). - Erythromycin 0.5% eye ointment prevents ophthalmia neonatorum (gonococcal/chlamydial eye infection). - Hepatitis B vaccine within 24 hours prevents vertical transmission and chronic HBV infection; HBIG is added if mother is HBsAg-positive. - BCG vaccine (intradermal) at birth prevents TB and is part of the Philippine EPI. - All newborns receive these medications/vaccines unless there is a specific contraindication (e.g., BCG in immunocompromised infants).

The **Newborn Screening Act of 2004 (Republic Act No. 9288)**, signed into law in the Philippines, institutionalized newborn screening as a public health mandate. This law requires that all newborns undergo screening for certain congenital metabolic and endocrine disorders that, if undetected and untreated, cause intellectual disability, serious illness, or death—but are treatable if identified early. The NLE tests extensively on RA 9288, the conditions screened, the collection procedure, and the nurse's role in ensuring compliance and family engagement. **The Conditions Screened (Basic Panel):** The Philippine newborn screening program detects six core metabolic/endocrine disorders in the **basic panel** and now includes an **expanded newborn screening (ENS) panel** with 28+ conditions. The nurse must know the six core conditions: **1. Congenital Hypothyroidism (CH)** - Definition: Deficiency of thyroid hormone at birth, most commonly due to thyroid dysgenesis (aplasia, hypoplasia, or ectopic thyroid), dyshormonogenesis (enzyme defects in hormone synthesis), or central hypothyroidism (pituitary/hypothalamic dysfunction). - Incidence: Approximately 1 in 2,000–4,000 births. - Clinical Presentation (if untreated): Delayed growth and development, severe intellectual disability (formerly called cretinism), coarse facial features, cool skin, poor feeding, jaundice, hypotonia, and developmental regression within the first weeks to months. - Screening Method: Measurement of TSH (thyroid-stimulating hormone) and/or T4 (thyroxine) on the dried blood spot. High TSH and/or low T4 suggest hypothyroidism. - Treatment: Thyroid hormone replacement (levothyroxine) started as soon as possible; if begun in the first days to weeks, normal development is preserved. - Nursing Role: Ensure collection at the appropriate time, inform family of the importance of follow-up, and initiate treatment immediately upon confirmation of diagnosis. **2. Congenital Adrenal Hyperplasia (CAH)** - Definition: Autosomal recessive disorder of adrenal cortex enzyme deficiency (most commonly 21-hydroxylase deficiency), preventing normal cortisol and aldosterone synthesis. The deficiency causes accumulation of precursor hormones and excess androgen production. - Incidence: Approximately 1 in 12,000–15,000 births (higher in certain ethnic populations). - Clinical Presentation (if untreated): In females, virilization (ambiguous genitalia at birth); in both sexes, salt-wasting crisis (hyponatremia, hyperkalemia, hypotension, shock) can occur at 1–4 weeks of life if not identified. Severe salt-wasting CAH is life-threatening. - Screening Method: Measurement of 17-hydroxyprogesterone (17-OHP), a precursor hormone that accumulates; elevated 17-OHP suggests CAH (some screening programs also measure cortisol). - Treatment: Glucocorticoid and mineralocorticoid (aldosterone) replacement to suppress excess androgen and maintain electrolyte balance; early surgical reconstruction may be considered for virilized females. - Nursing Role: Educate the family on recognition of salt-wasting crisis (lethargy, poor feeding, vomiting, dehydration); ensure close follow-up and immediate medical attention if signs develop before confirmatory testing. **3. Galactosemia (GAL)** - Definition: Autosomal recessive disorder of galactose metabolism due to deficiency of galactose-1-phosphate uridylyltransferase (GALT), one of three enzyme defects causing galactosemia. Galactose cannot be converted to glucose and accumulates in blood, urine, and tissues. - Incidence: Approximately 1 in 25,000–40,000 births; varies by ethnicity. - Clinical Presentation (if untreated): Feeding difficulties, jaundice, cataracts (usually appears at 1–2 weeks of life from galactose accumulation in the lens), hepatomegaly, intellectual disability, and ovarian failure in females. - Screening Method: Measurement of galactose or galactose-1-phosphate in the dried blood spot; elevated levels suggest galactosemia. Confirmatory testing measures GALT enzyme activity. - Treatment: **Immediate switch to lactose-free formula** (galactose-free); continuation of breast milk or regular formula will worsen disease. If started early (before cataracts develop and before severe liver damage), prognosis is much better; however, some complications (intellectual disability, ovarian failure) may persist even with early treatment. - Nursing Role: Inform the family immediately (before confirmatory testing) to cease breastfeeding or formula if galactosemia is suspected, initiate lactose-free formula, and arrange urgent follow-up. This is a **medical emergency**. **4. Phenylketonuria (PKU)** - Definition: Autosomal recessive disorder of phenylalanine metabolism due to deficiency of the enzyme **phenylalanine hydroxylase**, which normally converts phenylalanine (an amino acid) to tyrosine. Phenylalanine accumulates in blood and tissues, particularly the brain. - Incidence: Approximately 1 in 10,000–15,000 births; varies by ethnicity. - Clinical Presentation (if untreated): Intellectual disability (from accumulation of phenylalanine and its metabolites in the brain), seizures, behavioral abnormalities, fair skin and hair (due to reduced melanin production from lack of tyrosine), and a musty or "mousy" odor to urine and sweat. - Screening Method: Measurement of plasma phenylalanine on the dried blood spot; elevated levels (>20 mg/dL or >2 mg/dL by some cutoffs) suggest PKU. Confirmatory testing measures plasma phenylalanine and phenylalanine/tyrosine ratio. - Treatment: **Strict phenylalanine-restricted diet** started as soon as possible (ideally within the first weeks of life); specialized medical foods low in phenylalanine are used. If dietary management is begun early (before 1 month of age), intellectual development is largely preserved; later initiation allows some intellectual disability to have already occurred. - Nursing Role: Educate the family on the phenylalanine-restricted diet, importance of adherence, and need for lifelong dietary management and periodic plasma phenylalanine monitoring. Support the family psychologically, as PKU management is a long-term commitment. **5. Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency** - Definition: X-linked disorder (more common in males) of red blood cell enzyme G6PD, which protects RBCs from oxidative damage. G6PD-deficient RBCs are more susceptible to hemolysis when exposed to oxidative stressors (infections, certain medications like sulfonamides and aspirin, fava beans). - Incidence: Highly variable; common in Mediterranean, African, and Asian populations; prevalence in the Philippines is ~0.5–2%. - Clinical Presentation (if unmanaged): Neonatal jaundice (from hemolysis), hemolytic crisis when exposed to oxidative triggers (fever, infection, medication, food), pallor, dark urine, and splenomegaly. - Screening Method: Measurement of G6PD enzyme activity on the dried blood spot; low or absent activity indicates deficiency. - Treatment: Avoidance of known triggers (certain medications, fava beans, infections); supportive care during hemolytic crises (hydration, possible blood transfusion if severe); folic acid supplementation. - Nursing Role: Inform the family of the diagnosis, educate on trigger avoidance (particularly medication education for parents and the child as they grow), and ensure the infant is monitored closely for jaundice. Provide a list of medications and foods to avoid. **6. Maple Syrup Urine Disease (MSUD)** - Definition: Autosomal recessive disorder of branched-chain amino acid (leucine, isoleucine, valine) metabolism due to deficiency of branched-chain alpha-ketoacid dehydrogenase complex. These amino acids and their metabolites accumulate. - Incidence: Approximately 1 in 185,000 births overall; varies by ethnicity (higher in certain Mennonite and Ashkenazi Jewish populations). - Clinical Presentation (if untreated): Lethargy, poor feeding, vomiting, hypoglycemia, seizures, coma, and death within the first weeks to months if untreated. The urine and body fluids have a distinctive sweet, maple syrup-like odor (hence the name). - Screening Method: Measurement of branched-chain amino acids (leucine, isoleucine, valine) or their metabolites on the dried blood spot; elevated levels suggest MSUD. - Treatment: Immediate dietary restriction of branched-chain amino acids using specialized medical formulas; supportive care and management of acute metabolic crises. - Nursing Role: Educate the family on the dietary management, provide support for feeding with specialized formula, and ensure urgent follow-up and initiation of dietary therapy. **Expanded Newborn Screening (ENS) Panel (28+ Conditions):** Many regions in the Philippines now offer expanded newborn screening, which detects additional conditions such as other organic acidemias, fatty acid oxidation disorders (e.g., medium-chain acyl-CoA dehydrogenase deficiency—MCADD), hemoglobinopathies (sickle cell disease), biotinidase deficiency, and others. The specific conditions screened may vary by facility; the nurse should be aware of the conditions screened in the local facility and ensure families understand the expanded scope. **The Newborn Screening Collection Process:** **Timing of Collection:** The dried blood spot sample is collected ideally **between 24 and 72 hours after birth**. This timing is important because: - The infant must be at least **24 hours old** so that feeding-dependent metabolites register (e.g., amino acids, organic acids) and the screening results are valid. A sample drawn before 24 hours may yield false negatives. - Collection should occur before hospital discharge (within 72 hours for most infants). - If the sample is drawn before 24 hours, **it must be repeated** at 1–2 weeks of age to ensure accuracy. **Collection Procedure:** 1. **Inform the family:** Explain the purpose, procedure, and importance of newborn screening. Obtain informed consent (per DOH guidelines and facility protocol). 2. **Prepare the equipment:** Use the standardized newborn screening card (available from the DOH or facility newborn screening program). Ensure the card is clean and dry. 3. **Warm the heel:** Gently massage or apply warm compresses to the infant's heel for 5–10 seconds to increase blood flow and make puncture easier. 4. **Clean the site:** Use an alcohol-based antiseptic wipe; allow to dry completely (alcohol can interfere with some screening tests). 5. **Puncture the heel:** Use a sterile, disposable heel lancet (usually 2.4 mm depth); puncture the lateral or medial heel (avoid the posterior heel, central plantar surface, or areas of previous puncture). A single puncture is preferable; if insufficient blood is obtained, a second puncture at a different site may be necessary. 6. **Collect blood:** Allow blood to flow freely; gently "milk" the heel if needed to increase flow. Fill all required circles on the screening card by touching the blood drop to the circle—do **NOT** smear or squeeze blood onto the card, as this can cause hemolysis and invalidate results. 7. **Check completeness:** Ensure all circles are filled completely and that the back of the card also has blood saturation (for some screening tests). 8. **Allow drying:** Place the card horizontally on a clean, dry surface and allow blood to dry completely (at least 3 hours, ideally overnight) before sealing or submitting. Do not use heat or artificial drying, which can denature some proteins. 9. **Complete the form:** Fill out all required information: infant name, date of birth, time of collection, mother's name, hospital/facility name, and healthcare provider signature. Ensure accuracy of dates and times. 10. **Submit the sample:** Send the dried blood spot card to the designated newborn screening laboratory within the facility or to the regional/central laboratory according to facility protocol. Include any relevant clinical information (e.g., prematurity, sick infant requiring monitoring). **Quality Control and Follow-up:** - The laboratory performs the screening tests and reports results to the healthcare facility, usually within 1–2 weeks. - **Normal results:** No further action is needed; family is informed that screening was normal. - **Positive or abnormal results:** The facility is notified and must immediately: 1. Contact the family to inform them of the positive result and the need for urgent confirmatory testing. 2. Arrange referral to a pediatric specialist or metabolic center for confirmatory diagnostic testing (e.g., elevated TSH on newborn screening for CH requires serum TSH, free T4, and possibly thyroid ultrasound). 3. Initiate empirical treatment if indicated and the diagnosis is highly suspected (e.g., immediately switch to lactose-free formula if galactosemia is suspected, do not wait for confirmation). 4. Document all communication with the family and referral in the health record. 5. Ensure follow-up is completed and family adheres to management. **Nursing Role and Responsibilities (RA 9288):** Under RA 9288 and Philippine nursing standards, the nurse's responsibilities in newborn screening include: 1. **Education:** Provide clear, understandable information to the parents about the purpose of newborn screening, the conditions being screened for, and the procedure. Use culturally appropriate language and address parental concerns or misconceptions. 2. **Informed Consent:** Obtain informed consent (verbal or written per facility policy) from the parents before collection. Document consent in the health record. 3. **Accurate Collection:** Perform heel-prick collection using aseptic technique, proper site selection, and careful filling of the screening card. Poor collection is a common cause of invalid results and delays in diagnosis. 4. **Accurate Documentation:** Complete all required fields on the newborn screening card and submit form with precise information (dates, times, names). Errors in documentation can delay processing and reporting. 5. **Follow-up Communication:** If the facility receives positive results, the nurse plays a key role in: - Notifying the family with compassion and clarity. - Explaining the positive result and the next steps (confirmatory testing, specialist referral, possible interim management). - Providing written information about the condition and resources for the family. - Ensuring the family understands the urgency and importance of follow-up. - Documenting all communication in the health record. 6. **Coordination of Care:** Ensure that referrals to specialists are completed, that the family attends appointments, and that treatment (if needed) is initiated promptly. 7. **Family Support:** Provide emotional support to families who receive positive results; connect families with resources, support groups, and education about the condition and long-term management. 8. **Advocacy:** Advocate for timely screening, accurate collection, and equitable access to newborn screening services for all newborns in the facility, regardless of socioeconomic status. **Key NLE Points on Newborn Screening:** - RA 9288 mandates newborn screening in the Philippines. - Collection is performed at **24–72 hours of age** (sample before 24 hours must be repeated). - The six core conditions are CH, CAH, GAL, PKU, G6PD, and MSUD. - Heel-prick blood is spotted onto a standardized filter card and dried completely before submission. - Positive results require urgent follow-up, confirmatory testing, and specialist referral. - Some conditions (e.g., galactosemia) require immediate empirical treatment even before confirmation. - The nurse's role includes education, accurate collection, follow-up communication, and family support.

A major theme in NLE newborn questions is distinguishing **normal newborn variations** (benign findings that do not require intervention and should reassure families) from **abnormal or concerning findings** (that warrant escalation of care and investigation). The nurse must have confidence in recognizing normal variants and avoid unnecessary alarm, while remaining vigilant for true pathology. **Benign Newborn Findings (Reassure the Family):** **Acrocyanosis:** Bluish discoloration of the hands and feet, appearing in the first hours to days of life and gradually resolving by the end of the first week. This is **completely normal** and reflects slow peripheral blood flow and peripheral vasoconstriction in response to the cool environment. Acrocyanosis does not indicate cardiopulmonary disease or hypoxia. Assure the family: "Your baby's hands and feet are a bit blue, which is very common and normal. This happens because the baby's circulation is still adjusting to breathing air. It will disappear within a few days." **Milia:** Tiny, pearly white dots on the nose, cheeks, chin, and sometimes the palate. Milia are **sebaceous (oil) glands** that are not yet fully developed and appear as small cysts. They are benign and disappear spontaneously by 2–4 weeks as the skin matures. Do not attempt to squeeze or treat them (risk of infection). Assure: "These are tiny oil glands that will clear on their own." **Mongolian Spots:** Bluish-gray or greenish-gray pigmentation, typically over the sacrum and buttocks but can appear over the lower back, shoulders, and extremities. These are particularly common in **Filipino, African, and Asian infants**. Mongolian spots are collections of melanin-containing cells in the dermis and are completely benign. They gradually fade over months to years and are not present by school age in most cases. **Critical nursing point: Document Mongolian spots carefully in the health record** so they are not mistaken for bruising or signs of abuse in future healthcare encounters. Assure: "These are birthmarks caused by extra pigment under the skin. They are very common in babies of darker skin tones and will fade over time. They have nothing to do with the baby's health." **Erythema Toxicum:** A transient, benign newborn rash appearing in the first few days of life, characterized by small red papules (sometimes with vesicles) on the face, chest, and extremities. The rash appears, fades, and reappears in different areas. **It is not contagious** and does not require treatment. It resolves spontaneously by 1–2 weeks. Microscopic examination shows eosinophils (not bacteria or virus), confirming the benign nature. Assure: "This is a common rash in newborns that looks like small red bumps and pimples. It's completely harmless and will go away on its own." **Caput Succedaneum:** Scalp edema (swelling) that develops as a result of prolonged pressure of the scalp against the maternal pubic symphysis during labor. The swelling is localized to the area that presented first and **crosses the suture lines** (this is a key distinguishing feature). Caput succedaneum is pitting (depression made by finger pressure on the swollen area). The swelling is soft and compressible. It appears at birth and gradually resolves over the first few days as the edema reabsorbs. No treatment is necessary. Assure: "Your baby's head is a bit swollen from pushing through the birth canal. This swelling will go away in a few days." **Cephalohematoma:** A collection of blood between the periosteum (membrane covering the skull bone) and the bone itself, resulting from tearing of blood vessels during delivery trauma (vacuum extraction, forceps, or prolonged labor). Unlike caput succedaneum, a cephalohematoma is a **discrete, firm swelling that does NOT cross suture lines** (it is contained beneath a single skull bone). It appears within the first 24–48 hours of life (caput is present immediately). The swelling is soft initially but firms up as blood clots. Cephalohematomas are usually asymptomatic, but the nurse must: - Monitor for jaundice (as blood breakdown releases bilirubin; risk of pathologic hyperbilirubinemia). - Monitor for signs of infection (rare). - Reassure the family that the collection will be reabsorbed over weeks to months (rarely leaves a small calcified mass). - Avoid aggressive massage or aspiration (risk of infection and rebleeding). Cephalohematoma itself is not dangerous, but requires monitoring. **Pseudomenstruation (Pseudovaginal Bleeding):** Vaginal bleeding or bloody mucus discharge in the first week of life, caused by withdrawal of maternal estrogen. This finding is **benign and expected** in some newborn girls and is completely self-limited. Assure: "Your baby girl may have a small amount of bleeding from the vagina in the first few days. This is due to hormones from the mother and will stop on its own." **Breast Engorgement and Swollen Genitalia:** Both male and female newborns may have swollen/enlarged breast tissue (in both sexes), swollen labia or scrotum, and even milk discharge (galactorrhea) from the breast in the first week. These findings result from **maternal hormones** (estrogen and progesterone) passed in utero and across the placenta. They are completely benign and resolve spontaneously within 1–2 weeks as maternal hormones are cleared. Warn the family not to manipulate or squeeze the breast tissue (risk of abscess). Assure: "This swelling is from your baby's exposure to your hormones before birth and will go away within a few days to a week." **Physiologic Peeling of Skin:** The outermost layer of skin (stratum corneum) may peel in large flakes or sheets, particularly over the hands, feet, and trunk, in the first 1–2 weeks. This is completely normal and requires no treatment. Avoid excessive bathing or lotions. Assure: "Your baby's skin is shedding the outermost layer, which is normal. Just use gentle bathing and plain water; lotion is not needed." **Jaundice (Physiologic):** Yellow discoloration of the skin and sclera (white of the eyes) appearing after the first 24 hours of life, peaking at 3–5 days, and gradually resolving by 1–2 weeks (in term infants). Physiologic jaundice is caused by the breakdown of fetal hemoglobin and the immaturity of the liver's bilirubin-conjugating enzyme system. **It is normal and expected** in most newborns but requires monitoring because severe or rapidly rising hyperbilirubinemia can cause bilirubin encephalopathy (kernicterus), a serious neurologic condition. The nurse must: - Assess jaundice daily using visual inspection (appearing from face downward: face → trunk → extremities indicates increasing bilirubin) and serum bilirubin measurement if indicated. - Promote early and frequent breastfeeding to enhance bilirubin excretion. - Plot bilirubin levels on the phototherapy nomogram for the infant's age to determine if phototherapy is indicated. - Educate the family on warning signs (lethargy, poor feeding, high-pitched cry, fever) that might indicate pathologic hyperbilirubinemia or other illness. See a dedicated jaundice chapter for in-depth management; here, physiologic jaundice is noted as a common, expected finding that requires monitoring but is not pathologic if managed appropriately. **Doll's Eye Reflex (Oculocephalic Reflex):** When the infant's head is turned to one side, the eyes initially remain fixed in the midline before slowly turning in the direction of head movement (this is called "doll's eyes" because it resembles the eye movement in dolls). This is a normal primitive reflex in newborns and gradually disappears as visual fixation develops (by 4–6 weeks). It does not indicate neurologic disease. **Abnormal Findings (Report Immediately):** **Central Cyanosis:** Bluish discoloration of the lips, tongue, trunk, and central circulation—different from acrocyanosis (which affects only extremities). Central cyanosis indicates hypoxemia and is always abnormal. It suggests respiratory distress, cardiac disease, or severe hemoglobin abnormality. Actions: Assess respiratory effort, heart rate, and oxygen saturation immediately; provide oxygen if SaO2 <95%; escalate care. **Bulging Anterior Fontanelle:** The anterior soft spot should be soft, flat, or slightly sunken. A bulging fontanelle (feels tense and full) when the infant is calm and upright may indicate increased intracranial pressure from hydrocephalus, bleeding, or infection. Conversely, a markedly sunken fontanelle (deeply depressed) suggests dehydration or poor nutrition. Either extreme warrants evaluation. **Asymmetric or Absent Moro Reflex:** As discussed, asymmetry suggests clavicle fracture or brachial plexus injury (Erb palsy). Bilateral absence suggests severe CNS depression or neurologic disease. Report immediately. **Single Palmar Crease with Other Dysmorphic Features:** A single crease across the entire palm (instead of the normal two creases) can be a normal variant, but when present with other abnormal features (unusual facial features, growth restriction, cardiac murmur), it may suggest a chromosomal abnormality such as Down syndrome (Trisomy 21). The combination of findings (not the palmar crease alone) warrants genetic evaluation. **Signs of Respiratory Distress:** Grunting, nasal flaring, intercostal/subcostal retractions, seesaw respirations (abdomen in, chest out), and RR >60 at rest all indicate the infant is struggling to breathe and require escalation of care, supplemental oxygen, and possible mechanical support. **Suspected Sepsis/Infection:** Signs include temperature instability (fever >38°C or hypothermia <36°C), poor feeding, lethargy, irritability, weak cry, jaundice, vomiting, abdominal distention, or meconium staining of the skin/cord. Any suspected infection warrants immediate medical evaluation, blood cultures, and possible empirical antibiotics. **Cleft Palate or Cleft Lip:** A cleft in the palate (hard or soft) or lip is visible on examination. While not an emergency per se, it requires early notification to the physician/family and plans for feeding support and surgical repair. Feeding may require a special nipple or bottle. **Major Congenital Anomalies:** Obvious anomalies such as a meningomyelocele (exposed spinal cord/nervous tissue), gastroschisis (abdominal wall defect with exposed bowel), or severe hydrocephalus require immediate physician notification and may necessitate urgent surgical intervention or transfer to a higher-level facility. **Documentation and Communication:** Always document all findings clearly, distinguishing benign variants from concerning findings. Communicate reassuring findings to the family in accessible language, and escalate abnormal findings with appropriate urgency to the physician/midwife and higher-level care as needed.